SE8902507L - Neutrofil-aktiverande faktor - Google Patents

Neutrofil-aktiverande faktor

Info

Publication number
SE8902507L
SE8902507L SE8902507A SE8902507A SE8902507L SE 8902507 L SE8902507 L SE 8902507L SE 8902507 A SE8902507 A SE 8902507A SE 8902507 A SE8902507 A SE 8902507A SE 8902507 L SE8902507 L SE 8902507L
Authority
SE
Sweden
Prior art keywords
activating factor
naf
neutrophil activating
synthetic
neutrophil
Prior art date
Application number
SE8902507A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8902507D0 (sv
Inventor
H Aschauer
Original Assignee
Sandoz Ag
Kocher Theodor Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27263673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8902507(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878727053A external-priority patent/GB8727053D0/en
Priority claimed from GB888805070A external-priority patent/GB8805070D0/en
Priority claimed from GB888825258A external-priority patent/GB8825258D0/en
Application filed by Sandoz Ag, Kocher Theodor Inst filed Critical Sandoz Ag
Publication of SE8902507D0 publication Critical patent/SE8902507D0/xx
Publication of SE8902507L publication Critical patent/SE8902507L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8902507A 1987-11-19 1989-07-11 Neutrofil-aktiverande faktor SE8902507L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878727053A GB8727053D0 (en) 1987-11-19 1987-11-19 Neutrophil-activating factor(naf)
GB888805070A GB8805070D0 (en) 1988-03-03 1988-03-03 Neutrophil-activating factor(naf)
GB888825258A GB8825258D0 (en) 1988-10-28 1988-10-28 Neutrophil-activating factor
PCT/EP1988/001025 WO1989004836A1 (en) 1987-11-19 1988-11-12 Neutrophil-activating factor

Publications (2)

Publication Number Publication Date
SE8902507D0 SE8902507D0 (sv) 1989-07-11
SE8902507L true SE8902507L (sv) 1989-07-11

Family

ID=27263673

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902507A SE8902507L (sv) 1987-11-19 1989-07-11 Neutrofil-aktiverande faktor

Country Status (23)

Country Link
US (1) US6383479B1 (ja)
JP (1) JP3133305B2 (ja)
KR (1) KR890701625A (ja)
AT (1) ATA901588A (ja)
AU (1) AU622125B2 (ja)
BE (1) BE1001817A5 (ja)
CH (1) CH680001A5 (ja)
DE (2) DE3890998T1 (ja)
DK (1) DK354389A (ja)
ES (1) ES2014546A6 (ja)
FI (1) FI893474A (ja)
FR (1) FR2623400B1 (ja)
GB (1) GB2223225B (ja)
GR (1) GR880100775A (ja)
HU (1) HU205617B (ja)
IL (1) IL88404A0 (ja)
IT (1) IT1224574B (ja)
NL (1) NL194982C (ja)
NZ (1) NZ226990A (ja)
PL (1) PL275881A1 (ja)
PT (1) PT89026B (ja)
SE (1) SE8902507L (ja)
WO (1) WO1989004836A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652338A (en) * 1988-03-16 1997-07-29 The United States Of America As Represented By The Department Of Health And Human Services Neutrophil chemotactic factor
WO1990000563A1 (en) * 1988-07-07 1990-01-25 United States Government, As Represented By The Department Of Health & Human Services A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
EP0429542B1 (en) * 1988-08-15 1995-12-06 Brigham And Women's Hospital Leukocyte adhesion inhibitor
DE68919085T2 (de) * 1988-08-29 1995-04-06 Dainippon Pharmaceutical Co Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist.
JP2844260B2 (ja) * 1988-11-10 1999-01-06 ステファン チャールズ マックケイブ シャワーヘッド組立体
US5241049A (en) * 1989-12-22 1993-08-31 Zymogenetics, Inc. Neutrophil chemoattractants
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
IE913192A1 (en) * 1990-09-12 1992-02-25 Scripps Research Inst Active site of interleukin-8: polypeptide analogs and¹antibodies
WO1993001826A1 (en) * 1991-07-19 1993-02-04 East Carolina University Method of treating asthma
US5401651A (en) * 1991-10-16 1995-03-28 Walz; Alfred DNA encoding ENA-78, a neutrophil activating factor
GB9124775D0 (en) * 1991-11-21 1992-01-15 Medical Res Council Cervical ripening
CA2124461A1 (en) * 1991-12-04 1993-06-10 Ian Clark-Lewis Human interleukin-8 analogs
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
CN114391095A (zh) * 2019-06-27 2022-04-22 比纳瑞有限责任公司 适用于即时(poc)诊断测试绝对嗜中性粒细胞功能(anf)的即时(poc)测量的全血和体液中吞噬性白细胞的基于氧化酶的化学发光测定

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5652338A (en) * 1988-03-16 1997-07-29 The United States Of America As Represented By The Department Of Health And Human Services Neutrophil chemotactic factor
JPH03505037A (ja) 1988-05-02 1991-11-07 大日本製薬株式会社 ヒト好中球走化因子ポリペプチドの製造方法
EP0429542B1 (en) 1988-08-15 1995-12-06 Brigham And Women's Hospital Leukocyte adhesion inhibitor
AU4665689A (en) * 1989-12-11 1991-07-18 Wallac Oy Elastic scintillator material

Also Published As

Publication number Publication date
FR2623400B1 (fr) 1995-06-23
SE8902507D0 (sv) 1989-07-11
HU886790D0 (en) 1990-01-28
PT89026A (pt) 1988-12-01
HU205617B (en) 1992-05-28
DK354389D0 (da) 1989-07-18
IT1224574B (it) 1990-10-04
NL194982C (nl) 2003-04-10
ATA901588A (de) 1994-07-15
BE1001817A5 (fr) 1990-03-13
IT8848572A0 (it) 1988-11-18
CH680001A5 (ja) 1992-05-29
WO1989004836A1 (en) 1989-06-01
AU622125B2 (en) 1992-04-02
DE3890998T1 (de) 1991-02-21
FR2623400A1 (fr) 1989-05-26
GB8913271D0 (en) 1989-12-06
GB2223225A (en) 1990-04-04
NL8820928A (nl) 1989-10-02
DK354389A (da) 1989-09-19
KR890701625A (ko) 1989-12-21
GR880100775A (el) 1994-03-31
ES2014546A6 (es) 1990-07-16
US6383479B1 (en) 2002-05-07
AU2716288A (en) 1989-06-14
IL88404A0 (en) 1989-06-30
HUT52551A (en) 1990-07-28
DE3890998B4 (de) 2008-01-03
JPH02502825A (ja) 1990-09-06
PL275881A1 (en) 1989-07-24
GB2223225B (en) 1992-07-08
JP3133305B2 (ja) 2001-02-05
PT89026B (pt) 1993-02-26
FI893474A0 (fi) 1989-07-18
FI893474A (fi) 1989-07-18
NZ226990A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
SE8902507D0 (sv) Neutrofil-aktiverande faktor
ATE358176T1 (de) Menschliche dnase
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE69300158D1 (de) TGF-Beta induziertes Gen und Protein.
SE9002589L (sv) Neutrofil-aktiverande peptid-2
NO960309L (no) Agonister og antagonister for humaninterleukin-10
ATE256182T1 (de) Neuartiges p- selectin ligandenprotein
NO865191L (no) Gm-csf-protein, derivater derav og fremstilling og anvendelse av slike proteiner.
DK91389A (da) Kallikreiner, deres fremstilling og laegemidler indeholdende polypeptiderne
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ES2177625T3 (es) Citoquina cc-1 humana circulante.
MX9301535A (es) Material proteinaceo biologicamente activo aislado y purificado.
NO882792D0 (no) Fremstilling og anvendelse av promotere for ekspresjon av fremmed-dna i metylotrofebakterier.
DE69133159D1 (de) Chemotaktische faktoren
EP0315118A3 (en) Dna coding for endothelin and use thereof
MY103637A (en) Neutrophil-activating factor
CA2086835A1 (en) Tissue plasminogen activator variants with decreased clearance
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
IT8821282A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8821123A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8620345A1 (it) Vettore plasmidico ad espressione in bacillus utile per il clonaggio del gene strutturale che codifica per l'ormone della crescita umano e procedimento per la produzione di detto ormone

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8902507-6

Effective date: 19921206